Dr. Sender is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2040 E Mariposa Ave
El Segundo, CA 90245Phone+1 213-266-5600
Education & Training
- Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1988 - 1989
- Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1986 - 1987
- University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1983 - 1986
- University of the WitwatersrandClass of 1982
Certifications & Licensure
- CA State Medical License 1984 - 2026
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database Start of enrollment: 2005 Aug 04
- Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients Start of enrollment: 2008 Mar 01
- Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsCognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?Tami John, Leonard S. Sender, Daniela A. Bota
Journal of Adolescent and Young Adult Oncology. 2016-09-01 - 19 citationsPediatric cancer patients' treatment journey: Child, adolescent, and young adult cancer narrativesNancy Kuntz, Antoinette Anazodo, Vicky R. Bowden, Leonard S. Sender, Heather Morgan
Journal of Pediatric Nursing. 2019-09-01 - 96 citationsGastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosisSeesandra V. Rajagopala, Shibu Yooseph, Derek M. Harkins, Kelvin J. Moncera, Keri B. Zabokrtsky
BMC Genomics. 2016-08-15
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationLeslie Appiah, Leonard Sender, Oxford University Press
Press Mentions
- ImmunityBio Announces Authorization to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19July 14th, 2021
- ImmunityBio Expands Trials of T-cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South AfricaMay 25th, 2021
- NantKwest Names Pediatric VPMay 16th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: